Resource Center

25 RESULTS FOUND

AdvaMedDx Statement at Public Meeting of the Presidential Advisory Council for CARB

September 9, 2016

Overview of Diagnostic Test Technologies

August 22, 2016

Value of Molecular Diagnostics

August 22, 2016

Risk-Based Approach to Regulation of Diagnostics

August 15, 2016

Comments to FDA on LDT Framework

August 3, 2016

Introduction to Molecular Diagnostics, The Essentials of Diagnostics Series (PDF)

August 3, 2016

Payment Reform & Deficit Reduction Infographic

August 1, 2016

AdvaMedDx Letter to HHS Secretary Burwell on Common Rule NPRM

June 14, 2016

A Public Health Perspective on Antimicrobial Resistance Diagnostics: CDC-AdvaMedDx Meeting Report

March 1, 2016

The Importance of Diagnostic Tests in Fighting Infectious Diseases

February 2, 2016

The Value of Diagnostics in Detecting Cervical Cancer

January 1, 2016

The Value of Molecular Diagnostics: Advancing Cancer Treatment and Care

January 1, 2016

Executive Summary: The Value of Molecular Diagnostics: Advancing Cancer Treatment and Care

November 30, 2015

AdvaMedDx Comments to CMS Regarding Clinical Diagnostic Laboratory Tests Payment System Proposed Rule

November 24, 2015

AdvaMedDx Statement at CMS Clinical Laboratory Public Meeting July 2015

July 16, 2015

Comments to FDA on Next Generation Sequencing

March 20, 2015

Comments to FDA on Staff-Flow Cytometric Devices

January 12, 2015

AdvaMedDx Comments to 21st Century Cures Request for Feedback

January 5, 2015

Comments to FDA on Staff-Flow Cytometric Devices

January 5, 2015

Stakeholder Statements on the Regulation of Laboratory Developed Tests

September 19, 2014

AdvaMedDx Testimony to House Energy & Commerce Committee on Regulation of Laboratory Developed Tests

September 9, 2014

AdvaMed Comments to the Sunshine Act

August 29, 2014

Comments to FDA on Proposed Reclassification of Flu Tests

August 20, 2014

Glossary of Commonly Used Diagnostic Terms (PDF)

August 3, 2014

AdvaMedDx Sunshine Brochure for Physicians

August 1, 2014

Pages